DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
Meaghan joined Halloran Consulting Group in 2017. She brings more than 20 years of experience with pre-and post-market medical devices and Phase I-IV drug trial experience. She has extensive experience working with both pharmaceutical and device companies, proven management skills in industry settings, as well as experience in the development and execution of clinical programs. Wide-ranging expertise includes managing collaborations, departments, projects, programs, sites, vendors, monitoring, and process improvement initiatives. She utilizes her experience in clinical trial design, execution, and process improvement to drive transformation.
Meaghan has experience in both academic and industry settings with multi-center operations management and overseeing clinical trial management, clinical monitoring, and oversight of investigational sites. Meaghan successfully managed programs through the project life cycle of clinical study design and study publication utilizing a cross-functional team to deliver on time, precise results. Her responsibilities have included protocol writing, strategic contract/budget negotiations, as well as oversight of investigational site and vendor activities and performance. Meaghan supported continuous improvement in a previous role, through participation in focus groups.
Education:
University of Massachusetts Amherst, Bachelor of Science, Exercise Physiology
